Lynette Chui Yen Chee

Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant

Julian Lindsay, Jad Othman, Michelle K Yong, David Ritchie, Lynette Chee, KimHeng Tay, Shio Yen Tio, Ian Kerridge, Keith Fay, William Stevenson, Chris Arthur, Sharon C-A Chen, David CM Kong, Matthew Greenwood, Steven A Pergam, Catherine Liu, Monica A Slavin

Journal article  |  2021  |  TRANSPLANT INFECTIOUS DISEASE

BACKGROUND: The use of antithymocyte globulin (ATG) in allogeneic hematopoietic cell transplant (HCT) is associated with an increa..

Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation.

Nosha Farhadfar, Ajoy Dias, Tao Wang, Caitrin Fretham, Saurabh Chhabra, Hemant S Murthy, Larisa Broglie, Anita D'Souza, Shahinaz M Gadalla, Robert Peter Gale, Shahrukh Hashmi, A Samer Al-Homsi, Gerhard C Hildebrandt, Peiman Hematti, David Rizzieri, Lynette Chee, Hillard M Lazarus, Christopher Bredeson, Edgar A Jaimes, Amer Beitinjaneh, et al.

Journal article  |  2021  |  Transplant Cell Ther

Renal dysfunction is a recognized risk factor for mortality after allogeneic hematopoietic cell transplantation (alloHCT), yet our..

Myeloid somatic mutation panel testing in myeloproliferative neoplasms.

David M Ross, Candice Thomson, Nada Hamad, Steven W Lane, Kate Manos, Andrew P Grigg, Belinda Guo, Wendy N Erber, Ashleigh Scott, Nick Viiala, Lynette Chee, Maya Latimer, Courtney Tate, Carolyn Grove, Andrew C Perkins, Piers Blombery

Journal article  |  2021  |  Pathology

Myeloproliferative neoplasms are characterised by somatic mutations in pathways that regulate cell proliferation, epigenetic modif..

Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation

Ashvind Prabahran, Rachel Koldej, Lynette Chee, Eric Wong, David Ritchie

Journal article  |  2021  |  LEUKEMIA & LYMPHOMA

Poor Graft Function (PGF) is defined by multi-lineage cytopenias with complete donor chimerism post allogeneic transplantation, Ri..

CAR-T cell therapy and infection: a review

Olivia Bupha-Intr, Gabrielle Haeusler, Lynette Chee, Karin Thursky, Monica Slavin, Benjamin Teh

Journal article  |  2021  |  EXPERT REVIEW OF ANTI-INFECTIVE THERAPY

Introduction: Chimeric antigen receptor T-cell therapy (CAR-T cell therapy) is a novel immunotherapy with promising results in the..

Efficacy and safety results from ASCEMBL, a multicenter, open-label, phase 3 study of asciminib, a first-in-class STAMP inhibitor, vs bosutinib (BOS) in patients (Pts) with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with ≥2 tyrosine kinase inhibitors (TKIs)

A Hochhaus, C Boquimpani, D Rea, Y Minami, E Lomaia, S Voloshin, AG Turkina, DW Kim, J Apperley, JE Cortes, A Abdo, LM Fogliatto, DDH Kim, PD le Coutre, S Saussele, M Annunziata, TP Hughes, NA Chaudhri, LCY Chee, VG Gutiérrez, et al.

Journal article  |  2020  |  Blood

Introduction: Asciminib, unlike all approved TKIs that bind to the ATP site of the BCR-ABL1 oncoprotein, is a first-in-class STAMP..

Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.

Rohtesh S Mehta, Shernan G Holtan, Tao Wang, Michael T Hemmer, Stephen R Spellman, Mukta Arora, Daniel R Couriel, Amin M Alousi, Joseph Pidala, Hisham Abdel-Azim, Vaibhav Agrawal, Ibrahim Ahmed, A Samer Al-Homsi, Mahmoud Aljurf, Joseph H Antin, Medhat Askar, Jeffery J Auletta, Vijaya Raj Bhatt, Lynette Chee, Saurabh Chhabra, et al.

Journal article  |  2020  |  J Clin Oncol

PURPOSE: There is no consensus on the best choice of an alternative donor (umbilical cord blood [UCB], haploidentical, one-antigen..

Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.

Narendranath Epperla, Ang Li, Brent Logan, Caitrin Fretham, Saurabh Chhabra, Mahmoud Aljurf, Lynette Chee, Edward Copelan, César O Freytes, Peiman Hematti, Hillard M Lazarus, Mark Litzow, Taiga Nishihori, Richard F Olsson, Tim Prestidge, Wael Saber, Baldeep Wirk, Jean A Yared, Alison Loren, Marcelo Pasquini

Journal article  |  2020  |  Br J Haematol

Transplant-associated thrombotic microangiopathy (TA-TMA) is a complication of allogeneic transplantation (allo-HCT). The incidenc..

Recipient Age and Marked Thrombocytopenia Are Associated with Increased Mortality in Patients with Poor Graft Function Post Allogeneic Transplantation

Ashvind Prabahran, David Ritchie, Lynette CY Chee, Rachel Koldej

Conference Proceedings  |  2019  |  BLOOD

Introduction: Poor graft function (PGF) post allogeneic transplantation is defined as peripheral blood cytopenias i..

The Economic and Health Utilization Cost of Clinically Significant Cytomegalovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation

Michelle K Yong, Shio Yen Tio, Jake Valentine, Joe Sasadeusz, Lynette CY Chee, Ashish Bajel, David Ritchie, Monica Slavin

Conference Proceedings  |  2019  |  BLOOD

Introduction Understanding the economic impact of managing allogeneic hematopoietic stem cell transplant (HSCT) rec..